NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-232-2015-0-PCT-02 T Cells Modified to Overexpress C-MYB PCT PCT PCT/US2016/048435 Expired
NIAID E-293-2011-2-US-07 NUCLEIC ACID MOLECULES ENCODING FERRITIN-HEMAGGLUTININ FUSION PROTEINS US DIV 15/244,321 10137190 Issued PDF
NIAID E-145-2015-4-PCT-01 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV PCT PCT COMB PCT/US2016/048151 Expired
NCI E-298-2007-0-US-08 IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE US CON 15/244,882 Abandoned
NHLBI E-261-2012-0-US-03 IMAGING METHODS AND COMPUTER-READABLE MEDIA US DIV 15/243,765 11024018 Issued PDF
NIBIB E-229-2015-0-PCT-02 Systems And Methods For Multiview Nonlinear Optical Imaging For Improved Signal-to-Noise Ratio And Resolution In Point Scanning Multi-Photon Microscopy PCT PCT PCT/US2016/048058 Expired
NCI E-090-2000-1-US-14 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 US CON 15/241,996 10251912 Expired PDF
NCATS E-326-2008-0-AU-12 Activators Of Human Pyruvate Kinase AU DIV 2016216705 Issued
NCATS E-294-2009-0-US-06 Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders US CON 15/239,753 10039741 Issued PDF
NCI E-254-2005-2-AU-24 Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells AU DIV 2016216577 Issued
NIAID E-065-2018-0-PCT-02 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF PCT PCT PCT/US2016/052131 Expired
NINDS E-101-2012-1-HK-22 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS HK National Stage 19109787.0 Pending
NIDDK E-761-2013-0-KR-05 cGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display KR National Stage 10-2016-7022257 Abandoned
NIAID E-051-2002-0-US-18 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION US CON 15/237,316 10314908 Expired PDF
NHGRI E-217-2007-0-JP-13 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP DIV 2016-159061 Pending
NCI E-132-2012-0-US-05 ALTERING THE IMMUNODOMINANCE HIERARCHY USING A DNA VACCINE EXPRESSING CONSERVED REGIONS US CON 15/235,430 10426830 Issued PDF
NCI E-017-2006-0-US-06 ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS US CON 15/235,847 Abandoned
NCI E-204-2015-0-PCT-02 Near-IR Light-Cleavable Conjugates and Conjugate Precursors PCT PCT PCT/US2016/046582 Abandoned
NINDS E-143-2002-1-US-48 Method For The Treatment Of Multiple Sclerosis US CON 15/234,575 Abandoned
NCATS E-240-2011-0-US-03 GALACTOKINASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF ASSOCIATED DISEASES AND DISORDERS US CON 15/234,934 Abandoned
CC E-026-2015-0-PCT-02 Repeat Biopsy System And Method PCT PCT PCT/IB2016/054805 Expired
NIAID E-255-2016-0-US-03 CD-4 Mimetic Small Molecules Sensitize Human Immunogenicity Virus To Vaccine-elicited Antibody US National Stage 15/117,866 Abandoned
NIDCR E-190-2015-0-PCT-02 Methods Of Using Neodymium Magnet For Rapid Diagnosis Of Infectious And Autoimmune Diseases PCT PCT PCT/US2016/046037 Expired
NICHD E-206-2007-0-US-10 SUBSTRATE REDUCTION THERAPY US DIV 15/231,279 Abandoned
NCATS E-281-2015-0-AU-03 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER AU National Stage 2016306276 Abandoned
NCATS E-281-2015-0-PCT-02 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER PCT PCT PCT/US2016/045731 Expired
NCI E-079-2016-0-US-03 Biomarkers for Assessing Cancer Patients for Treatment US National Stage 15/116,925 Abandoned
NCATS E-281-2015-0-BR-04 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER BR National Stage BR1120180025992 Pending
NCATS E-281-2015-0-IN-07 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER IN National Stage 201837005050 Pending
NCATS E-281-2015-0-MX-10 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER MX National Stage MX/a/2018/001576 Pending
NCATS E-281-2015-0-JP-08 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER JP National Stage 2018-526611 Pending
NCATS E-281-2015-0-KR-09 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER KR National Stage 2018-7006536 Pending
NCATS E-281-2015-0-ZA-13 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER ZA National Stage 2018/01476 Pending
NCATS E-281-2015-0-RU-11 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER RU National Stage 2018107879 Pending
NCATS E-281-2015-0-US-12 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER US National Stage 15/750,805 Pending
NCATS E-281-2015-0-CN-14 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER CN National Stage 201680046606.6 Pending
NCATS E-281-2015-0-CA-05 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER CA National Stage 2995077 Pending
NCATS E-281-2015-0-EP-06 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER EP National Stage 16759907.5 Pending
NIAID E-055-2007-3-US-05 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN US CON 15/227,879 9896509 Issued PDF
NCI E-234-2014-1-IL-07 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF IL National Stage 247095 Pending
NCI E-244-2015-0-CA-04 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CA National Stage 2994694 Pending
NCI E-244-2015-0-PCT-02 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use PCT PCT PCT/US16/045289 Expired
NCI E-249-2015-0-TW-03 Modified Yeast-Brachyury Immunotherapeutic Compositions. TW ORD 105124349 Pending
NCI E-231-2015-0-IN-06 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer IN National Stage 201817003662 Issued
NCI E-231-2015-0-CA-03 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer CA National Stage 2994822 Issued
NCI E-231-2015-0-JP-07 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer JP National Stage 2018-506147 Issued
NIAID E-253-2011-3-US-09 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US DIV 15/226,744 9783595 Issued PDF
NCI E-231-2015-0-PCT-02 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer PCT PCT PCT/US2016/045090 Expired
NCI E-231-2015-0-EP-05 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer EP National Stage 16748467.4 Pending
NCI E-231-2015-0-CN-10 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer CN National Stage 201680058783.6 Pending